Contact
Please use this form to send email to PR contact of this press release:
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
TO:
Please use this form to send email to PR contact of this press release:
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
TO: